PTGX
PTGX
NASDAQ · Biotechnology

Protagonist Therapeutics Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$115.03
+2.17 (+1.92%)
Analyst Consensus
Strong Buy
20
Analysts
High
Coverage
Buy 18 90%
Hold 2 10%
Sell 0 0%
Price Target
Analyst Price Target -73.5% upside
Low Target $24.78
Average Target $30.47
High Target $49.57
Current Price $115.03
Current
$115.03
Target
$30.47
$24.78 $30.47 avg $49.57
Scenario Analysis
Bear Case
$24.78
-78.5%
Low target
Base Case
$30.47
-73.5%
Avg target
Bull Case
$49.57
+-56.9%
High target
Risk/Reward
0.7x
Unfavorable
Price in Context
52-Week High
$114.49
0.5% from high
52-Week Low
$49.38
+132.9% from low
50-Day SMA
$85.10
+35.2% vs SMA
200-Day SMA
$67.75
+69.8% vs SMA
RSI (14)
58.3
Neutral
Target vs 52W High
$30.47
-73.4% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 78% $257.58 +12.0%
AMGN
Amgen Inc
 Hold 44 50% $190.87 -44.6%
GILD
Gilead Sciences Inc
 Strong Buy 39 82% $362.68 +190.4%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 40 83% $438.34 -6.1%
REGN
Regeneron Pharmaceuticals
 Buy 38 71% $76.80 -87.5%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 37 76% $102.31 -64.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -31.2%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -37.5%